Hutchison China MediTech Limited (HCM) Social Stream



Hutchison China MediTech Limited (HCM): $17.06

0.26 (+1.55%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add HCM to Watchlist
Sign Up

Industry: China

Industry

A

Ranked

#30 of 42

in industry

HUTCHMED (CHINA) LTD (HCM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HCM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-20 3 $52 $40.3 $47.575 $16.61 186.42%
2022-03-10 4 $52 $46.25 $49.062 $16.61 195.38%
2022-03-16 4 $52 $30.35 $45.087 $16.61 171.44%
2022-05-02 4 $50 $22 $36.837 $16.61 121.78%
2022-06-08 5 $50 $22 $36.837 $16.61 121.78%
2022-08-02 5 $50 $20.25 $34.312 $16.61 106.57%
2022-08-08 6 $50 $14 $30.25 $16.61 82.12%
2022-08-13 6 $50 $16 $30.65 $16.61 84.53%
2022-11-14 6 $50 $16 $31.24 $16.61 88.08%
2022-12-15 6 $50 $16 $29.366 $16.61 76.8%
2023-01-26 5 $50 $16 $29.7 $16.61 78.81%
2023-02-08 4 $50 $16 $29.7 $16.61 78.81%
2023-03-08 6 $50 $16 $29.866 $16.61 79.81%
2023-04-25 6 $50 $16 $29.333 $16.61 76.6%
2023-06-06 5 $50 $16 $31.2 $16.61 87.84%
2023-08-01 5 $50 $14.6 $30.72 $16.61 84.95%
2023-08-04 6 $50 $14.6 $30.92 $16.61 86.15%
2023-08-21 5 $50 $14.6 $34.65 $16.61 108.61%
2023-11-10 6 $50 $14.6 $34.65 $16.61 108.61%
2023-11-16 6 $45 $14.6 $26.4 $16.61 58.94%
2023-11-24 7 $45 $14.6 $25.54 $16.61 53.76%

The Trend in the Analyst Price Target


Over the past 37 months, HCM's average price target has gone down $12.52.

HCM reports an average of 93.5% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 4 50 16.0 29.700 19.83 49.77%
2023-03-08 5 50 16.0 29.866 13.57 120.09%
2023-06-06 5 50 16.0 31.200 12.60 147.62%
2023-08-21 6 50 14.6 34.650 13.50 156.67%
2023-11-10 6 50 14.6 34.650 19.02 82.18%

HCM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 5 0 2 0 0 7

The Trend in the Broker Recommendations


Over the past 45 months, HCM's average broker recommendation rating worsened by 0.27.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCM as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, HUTCHMED (CHINA) LTD's variance in analysts' estimates is lower than -2164.56% of them.
  • HCM has a greater upside potential (average analyst target price relative to current price) than 2180.67% of all US stocks.
  • HUTCHMED (CHINA) LTD's number of analysts covering the stock is higher than 621.99% of all US stocks.
  • In the context of stocks in the mid market cap category, HUTCHMED (CHINA) LTD's average analyst price target is higher than 1296.67% of them.

Stocks similar to HUTCHMED (CHINA) LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ORGO, ANAB, and PTGX.

Make investment decisions regarding HCM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!